STAAR Surgical is trading at $27.50, up 10.26% pre-market, with no verified catalyst.
- Third-quarter 2026 results are scheduled after market close on November 4; analysts’ preview is not an earnings result or confirmed explanation.
- A regional leadership appointment announced October 29, effective November 2, is not established as the catalyst.
- No verified company-specific November 3 announcement explains the gain; available market context shows no broad same-direction move.